Making sense of missense variants in TTN-related congenital myopathies
Open Access
- 15 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Acta Neuropathologica
- Vol. 141 (3), 431-453
- https://doi.org/10.1007/s00401-020-02257-0
Abstract
Mutations in the sarcomeric protein titin, encoded by TTN, are emerging as a common cause of myopathies. The diagnosis of a TTN-related myopathy is, however, often not straightforward due to clinico-pathological overlap with other myopathies and the prevalence of TTN variants in control populations. Here, we present a combined clinico-pathological, genetic and biophysical approach to the diagnosis of TTN-related myopathies and the pathogenicity ascertainment of TTN missense variants. We identified 30 patients with a primary TTN-related congenital myopathy (CM) and two truncating variants, or one truncating and one missense TTN variant, or homozygous for one TTN missense variant. We found that TTN-related myopathies show considerable overlap with other myopathies but are strongly suggested by a combination of certain clinico-pathological features. Presentation was typically at birth with the clinical course characterized by variable progression of weakness, contractures, scoliosis and respiratory symptoms but sparing of extraocular muscles. Cardiac involvement depended on the variant position. Our biophysical analyses demonstrated that missense mutations associated with CMs are strongly destabilizing and exert their effect when expressed on a truncating background or in homozygosity. We hypothesise that destabilizing TTN missense mutations phenocopy truncating variants and are a key pathogenic feature of recessive titinopathies that might be amenable to therapeutic intervention.Keywords
Funding Information
- British Heart Foundation (RG/15/8/31480)
- Medical Research Council UK (MR/R003106/1)
- Myotubular Trust (12KCL01)
- National Institutes of Health (NS053672)
- Princes Beatrix muscle fund
- Deutsche Forschungsgemeinschaft (Cl 218/1-1)
- Australian NHMRC (GNT1090428)
This publication has 63 references indexed in Scilit:
- Genetic complexity in hypertrophic cardiomyopathy revealed by high-throughput sequencingJournal of Medical Genetics, 2013
- Titin mutation segregates with hereditary myopathy with early respiratory failureBrain, 2012
- Improving the Assessment of the Outcome of Nonsynonymous SNVs with a Consensus Deleteriousness Score, CondelAmerican Journal of Human Genetics, 2011
- The Giant Protein Titin: A Regulatory Node That Integrates Myocyte Signaling PathwaysOnline Journal of Public Health Informatics, 2011
- Structural insight into M-band assembly and mechanics from the titin-obscurin-like-1 complexProceedings of the National Academy of Sciences of the United States of America, 2010
- Interactions with titin and myomesin target obscurin and obscurin-like 1 to the M-band – implications for hereditary myopathiesJournal of Cell Science, 2008
- The Kinase Domain of Titin Controls Muscle Gene Expression and Protein TurnoverScience, 2005
- Subcellular targeting of metabolic enzymes to titin in heart muscle may be mediated by DRAL/FHL-2Journal of Cell Science, 2002
- Tibial Muscular Dystrophy Is a Titinopathy Caused by Mutations in TTN, the Gene Encoding the Giant Skeletal-Muscle Protein TitinAmerican Journal of Human Genetics, 2002
- Localization of epitopes and functional effects of two novel monoclonal antibodies against skeletal muscle myosinJournal of Muscle Research and Cell Motility, 1990